Potomac Capital Management, Inc.

Position in GANX — Gain Therapeutics, Inc.

CIK 1418746 NEW YORK, NY

Position in GANX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,921,192

-$35,492 QoQ

Shares Held

946,400

-6.2% QoQ

Ownership

2.17%

of shares outstanding

% of Portfolio

1.49%

of 13F equity value

Holder Rank

of 49 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Potomac Capital Management, Inc. holds $4,921,092 across 3 Biotechnology names. GANX ranks #2 (39.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	FENC	Fennec Pharmaceuticals Inc.	224,400	$2,412,300
2	GANX	Gain Therapeutics, Inc. This page	946,400	$1,921,192
3	CDXS	Codexis, Inc.	260,000	$587,600

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,921,192	946,400	-6.2%	Shares	Sole	2026-08-14
2026-03-31	$1,956,684	1,008,600	-0.1%	Shares	Sole	2026-05-14
2025-12-31	$3,252,200	1,010,000	—	Shares	Sole	2026-02-11
No filing history on record for this holder in this stock.